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Abstract
Background: Trauma/hemorrhagic shock (T/HS) results in cytokine-mediated acute inflammation that is generally
considered detrimental.
Methodology/Principal Findings: Paradoxically, plasma levels of the early inflammatory cytokine TNF-a (but not IL-6, IL-10,
or NO2
-/NO3
-) were significantly elevated within 6 h post-admission in 19 human trauma survivors vs. 4 non-survivors.
Moreover, plasma TNF-a was inversely correlated with Marshall Score, an index of organ dysfunction, both in the 23 patients
taken together and in the survivor cohort. Accordingly, we hypothesized that if an early, robust pro-inflammatory response
were to be a marker of an appropriate response to injury, then individuals exhibiting such a response would be predisposed
to survive. We tested this hypothesis in swine subjected to various experimental paradigms of T/HS. Twenty-three
anesthetized pigs were subjected to T/HS (12 HS-only and 11 HS + Thoracotomy; mean arterial pressure of 30 mmHg for
45–90 min) along with surgery-only controls. Plasma obtained at pre-surgery, baseline post-surgery, beginning of HS, and
every 15 min thereafter until 75 min (in the HS only group) or 90 min (in the HS + Thoracotomy group) was assayed for
TNF-a, IL-6, IL-10, and NO2
-/NO3
-. Mean post-surgery6HS TNF-a levels were significantly higher in the survivors vs. non-
survivors, while non-survivors exhibited no measurable change in TNF-a levels over the same interval.
Conclusions/Significance: Contrary to the current dogma, survival in the setting of severe, acute T/HS appears to be
associated with an immediate increase in serum TNF-a. It is currently unclear if this response was the cause of this
protection, a marker of survival, or both. This abstract won a Young Investigator Travel Award at the SHOCK 2008 meeting in
Cologne, Germany.
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Introduction
Traumatic injury/Hemorrhagic shock (T/HS) is a major source
of morbidity and mortality worldwide [1]. It is ranked the fifth
leading cause of death in all age groups in the United States, where
it remains the leading cause of death in individuals under the age
of 44 years of age [2]. Regardless of the mechanism of injury, HS
is a leading cause of death following trauma [1,3,4]. Trauma and
hemorrhage trigger a complex cascade of events associated with
alterations in hemodynamic, metabolic, and inflammatory/
immune responses that are largely orchestrated by cytokines and
chemokines, among a host of factors [5–7]. Over the past two
decades, much has been learned about how cytokines modulate
inflammation and associated processes [8,9]. However, the exact
role of each cytokine in the setting of trauma/hemorrhage is still
unknown [7]. Some cytokines appear to promote inflammation in
the context of traumatic injury, whereas other cytokines suppress
the activity of these nominally pro-inflammatory cytokines [10,11].
Nonetheless, the current paradigm equates elevated inflammation
with adverse outcomes [12,13].
This notion is increasingly being challenged, given the beneficial
aspects of a properly regulated post-injury inflammation, including
the orchestration of defenses against infection, as well as signaling
for proper tissue healing [14]. Determining the exact role of the
acute inflammatory response in the setting of T/HS is a highly
complex endeavor, given the redundant and interconnected nature
of inflammatory processes. The initial progression of the systemic
inflammatory response can have different manifestations, depend-
ing on the specific characteristics of the injury [15]; individual
genetics [16], wherein a gene polymorphism within the regulatory
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sequence affects the levels of cytokine production [10,17]; and the
robustness of the response to tissue damage and ischemia [18].
To date, the ‘‘classical’’, nominally pro-inflammatory (or more
properly, TH1) cytokines include tumor necrosis factor–a (TNF-a),
interleukin (IL)-1b, IL-2, IL-6, IL-8 [19–21] and IL-18 [22]. On the
other hand, nominally anti-inflammatory (TH2) cytokines such as
IL-10 counteract the effects of TH1 cytokines in various contexts
[23], including severe hemorrhagic shock [24]. Overproduction of
either pro-inflammatory cytokines or anti-inflammatory cytokines
may result in organ dysfunction [25], but it is unclear if these
outcomes are a function of the duration, magnitude, or rate at which
acute inflammation is triggered.
We sought to clarify the role of acute inflammation in human
trauma victims. Paradoxically, both morbidity and mortality were
inversely proportional to the degree of TNF-a production in
human trauma victims. Swine subjected to a modified Wiggers
paradigm of hemorrhagic shock recapitulated this basic finding.
Thus, we suggest that an adequately robust TNF-a response
following trauma may protect from death.
Materials and Methods
Human Trauma
All human sampling was done following approval by the
University of Pittsburgh Institutional Review Board and informed
consent was obtained from each patient or next of kin as per
Institutional Review Board regulations. Blood samples from
twenty-three (19 survivors: 12 males and 7 females, and 4 non-
survivors: 3 males and 1 female) human trauma victims of motor
vehicle accidents (17) or falls (6) were studied. The overall
demographics of the patients were as follows: age: 4764 yo; Injury
Severity Score (ISS): 2563; intensive care unit length of stay: 962;
total length of stay: 1362; number of days on a ventilator: 461.
Plasma was sampled within the first 6 h following trauma.
Animal Preparation
This study was approved by the University of Pittsburgh
Institutional Animal Care and Use Committee and conforms to
United States National Institutes of Health guidelines for the care
and use of laboratory animals. Animals were acclimatized for at
least five days in the Animal facility before being used in the
experimental study. Twenty-three juvenile female Yorkshire/
Durock pigs weighing approximately 25 to 35 kg (31.663.8 kg)
were fasted overnight with access to water ad libitum. In the
morning, they were sedated with an intramuscular injection of
Ketamine/Xylazine/Telazol (1.0 ml/22.72 kg) and then were
anesthetized with halothane inhalation to facilitate endotracheal
intubation.
Surgical Preparation
The experimental hemorrhage protocol was designed to
stimulate a dynamically changing clinical situation reproduced
by modifying a Wiggers model using progressive, discrete bleeding
episodes based on the animal’s physiologic response. During
surgical preparation, anesthesia was maintained with isoflurane
1.0%–2.0% (1.0%–1.5% end tidal concentration) while the
animals spontaneously ventilated oxygen/nitrogen (21%/79%)
through a semi-closed loop system.
Surgery Groups
Three pigs underwent surgical cannulation of the neck and
groin (controls for Group A) and 4 pigs underwent surgical
cannulation with an anterolateral thoracotomy (controls for
Group B).
Surgery/HS Groups
Pigs subjected to surgery and HS were divided into two groups,
according to the severity of surgical preparation: Group A
underwent neck and groin surgical cannulation whereas Group
B underwent neck and groin cannulation and left anterolateral
thoracotomy. Under aseptic conditions, the right external jugular
vein and carotid artery were identified through a surgical incision
in the neck and cannulated with a Swan-Ganz catheter (for blood
sample collection and pulmonary pressure measurements), as well
as, a Millar catheter (for blood pressure measurements), respec-
tively. The right femoral vein and artery were isolated through a
surgical incision at the groin and were cannulated using a bleeding
catheter and a triple lumen catheter (blood pressure measure-
ments). Group B was subjected to a left anterolateral thoracotomy
after cannulation and prior to hemorrhage, in which a pericardial
window was done and ultrasonic flow probes were placed on the
pulmonary artery and aorta. Finally, a pressure sensing catheter in
the left atrium was inserted. Physiological data were displayed on
an eight-channel clinical monitor (Hewlett-Packard).
Hemorrhage and Resuscitation Protocol in Swine
The following arterial pressure–driven experimental hemor-
rhage protocol was performed to exhaust the animals compensa-
tory capacity with respect to hemorrhage, and thus approach the
individual boundaries of irreversibility: A modified Wiggers model
was used in the bleeding protocol, in which swine were bled to a
predetermined hemodynamic endpoint. At the end of surgery, the
pig was stabilized for 15 to 30 min, at which time the experiment
was initiated (time 0). At time 0, controlled arterial hemorrhage via
the femoral vein was initiated using a roller pump at a rate of
60 ml/min. The volume of shed blood was collected in a closed
reservoir, and shed blood was collected in a reservoir and its
volume determined from reservoir weight. Hemorrhage was
sustained to maintain a mean arterial pressure (MAP) between
30 to 40 mmHg, with re-initialization of bleeding if the animal was
capable of compensating its MAP. Resuscitation was initiated
when the MAP fell below 30 mmHg for 10 min, below 20 mmHg
for 10 seconds or when the pig was capable of maintaining a MAP
between 30 and 40 mmHg for more than 90 min after the last
bleed. Volume resuscitation was initiated using Hextend (Hospira
Inc, Lake Forest, IL) at a rate of 60 ml/h. After resuscitation,
swine were observed for 2 h and then sacrificed. Surviving animals
were those that were alive up to 2 h post-resuscitation, whereas
those that died prior to 2 h post-resuscitation were defined as non-
survivors.
Collection of Porcine Blood Samples
The first blood sample was a venous sample drawn from the ear
immediately after intubation of the animals. This sample was used
as the pre-surgical baseline sample (denoted as PreSx BL). After
placement of the pulmonary artery catheter, mixed venous blood
samples were taken every 30 min from the first incision until surgery
was completed (denoted as S30, S60 etc). The post-surgical baseline
sample (denoted as PostSx BL) was designated as time 0, and
samples were collected every 30 min after until the commencement
of resuscitation (labeled as B0, B30, B60, etc). Blood samples were
taken after resuscitation (R) every 30 min (labeled as R30, R60, etc).
Blood samples were immediately centrifuged, and plasma was
stored at 280uC until further analysis.
Cytokines and NO2
-/NO3
- Analysis
TNF-a, IL-10, and IL-6 were measured using human-specific
LuminexTM beadsets (BioSource-Invitrogen, Austin, TX) using a
Robust Inflammation in Trauma
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LuminexTM 100 IS apparatus (MiraiBio, Austin, TX) or
commercially available, pig-specific ELISA kits (R&D Systems,
Minneapolis, MN) using a standard ELISA reader. NO2
-/NO3
-
was measured by the nitrate reductase method using a commer-
cially available kit (Cayman Chemical, Ann Arbor, MI).
Marshall Score (Multiple Organ Dysfunction Score)
Six variables were obtained from the trauma data registry
including a) the respiratory system (PO2/FIO2 ratio); b) the renal
system (serum creatinine concentration); c) the hepatic system
(serum bilirubin concentration); d) the hematologic system (platelet
count); e) the central nervous system (Glasgow Coma Scale) and f)
the cardiovascular system (PAR). Marshall Score was calculated
according to Marshall JC et al. [26].
Statistical Analysis
Statistical analysis was performed by ANOVA on ranks
followed by the Tukey post hoc test using Sigma Stat software
(Systat Software, San Jose, CA). To compare cytokine levels
between survivors and non-survivors in human trauma patients,
both Student’s t-test and the Mann-Whitney rank sum test were
applied using Sigma Stat software (Systat Software, San Jose, CA).
In all situations in which a statistically significant value is reported
(see below), both tests yielded similar results. Correlation between
analyte levels and Marshall Scores was assessed by using
Spearman’s rank correlation coefficient. For all statistical analyses,
results are expressed as mean6SEM except when otherwise noted,
and a P value of ,0.05 was considered significant.
Results
Inflammation Following Traumatic/Hemorrhagic Shock in
Humans
We initially examined the inflammatory responses to T/HS in
trauma patients. Twenty-three (19 survivors: 12 males and 7
females, and 4 non-survivors: 3 males and 1 female) human
trauma victims of motor vehicle accidents (17) or falls (6) were
studied (age: 4764 yo; ISS: 2563; ICU LOS: 962; total LOS:
1362; number of days on a ventilator: 461). The demographic
characteristics of the trauma survivors were the following: age:
4364 yo; ISS: 2563; ICU LOS: 962; total LOS: 1563; and
number of days on ventilator: 461). The demographic character-
istics of the trauma non-survivors were the following: age:
6666 yo (P=0.021); ISS: 2467; ICU LOS: 862; total LOS:
962; and number of days on ventilator: 762). The non-survivors
expired on days 3, 6, 12, and 13 post-admission. The mean
Marshall Score in all patients over the time range described above
was 3.1560.5. In survivors, the mean Marshall Score over the
same period of time was 2.560.45, whereas in non-survivors it was
661 (P=0.004).
In survivors of polytrauma, the mean levels of cytokines within
the first 6 h following trauma were: TNF-a (2263 pg/ml; range: 7–
47 pg/ml), IL-10 (76618 pg/ml; range: 14–352 pg/ml), and IL-6
(3816151 pg/ml; range: 29–2882 pg/ml). NO2
-/NO3
- levels were
3866 mM (range: 12 – 96 mM). In non-survivors, the mean levels of
cytokines were: TNF-a (463 pg/ml; range: 0–10 pg/ml), IL-10
(33626 pg/ml; range: 0–109 pg/ml), and IL-6 (202631 pg/ml;
range: 137–265 pg/ml). NO2
-/NO3
- levels were 3064 mM (range:
137 – 264 mM) (Fig. 1). A statistically significant difference between
survivors and non-survivors was only found for TNF-a (P=0.01;
Fig. 1A). In contrast, no statistical significant difference was
found for IL-10 (P=0.114; Fig. 1B), IL-6 (P=0.543; Fig. 1C), or
NO2
-/NO3
- (P=0.968; Fig. 1D).
Mortality post-T/HS in humans occurs typically secondary to
multiple organ failure [27]. Accordingly, we plotted the levels of
TNF, IL-6, IL-10, and NO2
-/NO3
- as a function of Marshall
Score, an index of organ failure, calculated at each blood sampling
time point (Fig. 2). We observed a highly significant (P=0.008)
negative correlation (correlation coefficient =20.58) between
circulating TNF-a and Marshall Score, taken across all time
points in all patients (survivors and non-survivors; Fig. 2A). This
finding held true even when examining only survivors (Fig. 2B;
P=0.004; correlation coefficient =20.66). While not directly
implying causality, these findings supported our observations
regarding a beneficial role of early TNF elevation (Fig. 1A). In
contrast, we observed a weaker, but still significant, positive
association between circulating IL-6 and Marshall Score taken
across all patients (Fig. 2C; P=0.044; correlation coeffi-
cient = 0.45). This trend remained but did not reach statistical
significance when examining only survivors (Fig. 2D; P=0.126;
correlation coefficient = 0.38). No statistically significant associa-
tions between inflammatory markers and Marshall Score were
observed when examining non-survivors only (data not shown).
These results led us to hypothesize that an early, elevated
inflammatory response in the form of the increased TNF-a
production was associated with survival. In contrast, we hypoth-
esized that since IL-6 is typically a marker of later inflammation,
and indeed may be a hallmark of the positive feedback cycle of
inflammationRtissue damage/dysfunctionRinflammation, then
elevations in this cytokine are indicative of a harmful, self-
sustaining inflammatory response. To test these hypotheses, we
carried out prospective studies in swine subjected to clinically
realistic T/HS.
Inflammation Following Hemorrhagic Shock in Swine
(Group A)
A total of 12 pigs (9 survivors and 3 non-survivors) were studied
in Group A, following the hemorrhage protocol and hemody-
namic parameters that would trigger resuscitation of the animals
are depicted in Fig. 3A. Shed blood volume in this group was
882663 ml (mean6SEM) in survivors and 1063690 ml in non-
survivors. The mean number of bleeds in both survivors and non-
survivors was 4, and the mean percent of total volume of blood
shed was between 50 and 55 in both survivors and non-survivors.
The time to resuscitation in survivors was 113615 min, whereas
in non-survivors it was 132631 min with no statistical significant
difference between time of resuscitation (P=0.557). Given that
survival in this experimental paradigm depended in part on
intervention by the investigators due to the triggering of defined
alarms indicative of hypotension (see Fig. 3A), it was necessary to
examine the inflammatory response only up to the point such
alarms were triggered, in order to test our hypothesis that robust
inflammatory responses were associated with a robust physiolog-
ical response of the animal to T/HS. No pigs died prior to the last
time point utilized in this analysis. The longest time point prior to
resuscitation found in common in both survivors and non-
survivors was 75 min; accordingly, this was the longest time point
utilized in our analyses. Blood sampling was carried out as
depicted in Fig. 3B.
We first examined the levels of TNF-a, IL-10, IL-6, and NO2
-/
NO3
- at all time points in survivors vs. non-survivors (Fig. 4). In
survivors, the mean levels of cytokines pre-resuscitation were as
follows: TNF-a (540660 pg/ml; range: 70–1467 pg/ml), IL-10
(3.660.9 pg/ml; range: 0–26 pg/ml), and IL-6 (2668 pg/ml;
range: 0–216 pg/ml). NO2
-/NO3
- levels were 5068 mM (range:
8–223 mM). In non-survivors, the mean levels of cytokines were as
follows: TNF-a (14168 pg/ml; range: 90–205 pg/ml), IL-10
Robust Inflammation in Trauma
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(1162 pg/ml; range: 0–35 pg/ml), and IL-6 (0.360.2 pg/ml;
range: 0–5 pg/ml). NO2
-/NO3
- levels were 5767 mM (range:
14–106 mM). Statistically significant differences between survivors
and non-survivors were found for TNF-a (P=0.015; Fig. 4A),
IL-10 (P=0.003; Fig. 4B), IL-6 (P=0.04; Fig. 4C) and NO2
-/
NO3
- (P=0.043; Fig. 4D).
We next examined the levels of inflammatory analytes as a
function of time in survivors vs. non-survivors. A statistically
significant difference in TNF-a was found between survivors and
non-survivors at several experimental time points (15 min post-
surgical baseline; at the start of hemorrhage [0]; and at 15, 30, 45,
60, and 75 min post-hemorrhage; Fig. 5A). A statistically
significant difference in circulating IL-10 was observed between
survivors and non-survivors at 15 min post-surgical baseline as
well as at 15 and 60 min post-hemorrhage (Fig. 5D). No
statistically significant difference was found in either IL-6 or
NO2
-/NO3
- levels between survivors and non-survivors (Supple-
mentary Materials, Table S1).
We next examined the trends in cytokines within groups. In
survivors, mean serum TNF-a at baseline was 7767 pg/ml, rose
in a statistically significant fashion following the initial surgery, and
remained elevated up to 75 min post-hemorrhage (with statisti-
cally significant changes vs. baseline at 0, 15, 30, 45, 60, and
75 min post-hemorrhage; Fig. 5A). In contrast, while the mean
baseline TNF-a value in non-survivors was similar to that of the
survivors (8969 pg/ml vs. baseline TNF-a in survivors), no
statistically significant change vs. baseline occurred either
following surgery or during the hemorrhage period (Fig. 5B). We
observed essentially the opposite behavior for IL-10: there was no
significant change in IL-10 in survivors from baseline (160.6 pg/
ml) which did not change over time (at 75 min was 361.4 pg/ml;
Fig. 5C), while non-survivors had a baseline IL-10 value of
161.3 pg/ml, which rose to 2067.7 pg/ml (with a significant
change at 60 min vs. pre-operative baseline; Fig. 5D). The levels of
IL-6 and NO2
-/NO3
- were uniformly low and unchanged in both
survivors (Figs. 5E and 5G, respectively) and non-survivors
(Figs. 5F and 5H, respectively; approximately 24 pg/ml IL-6
and 50 mM NO2
-/NO3
- vs. 0 pg/ml IL-6 and 59 mM NO2
-/
NO3
-, respectively) throughout the 75 min time course analyzed in
this study.
The control group (surgery only) for Group A (Supplementary
Materials, Fig. S1 and Table S2) exhibited low mean pre-operative
baseline levels of all cytokines and NO2
-/NO3
-, that remained low
throughout the observation time period (5.5 h). The levels of these
inflammatory analytes were as follows: TNF-a (mean levels pre-
operative baseline 7567 pg/ml vs. 75617 pg/ml at the end; Fig.
S1A), IL-10 (1267 pg/ml at baseline vs. 1462 pg/ml at the end;
Fig. S1B), IL-6 (below detection limit at baseline vs. 565 pg/ml at
the end; Fig. S1C), and NO2
-/NO3
- (3769 mM vs. 2465 mM at
the end; Fig. S1D).
The results observed in the T/HS pigs supported the
hypothesis, derived from the observation of human trauma
Figure 1. Plasma cytokine and nitrite/nitrate levels in human trauma patients. Plasma samples from 23 patients (19 survivors and 4 non-
survivors) taken within the first 6 h following trauma were assayed for TNF-a (A), IL-10 (B), IL-6 (C) and NO2
-/NO3
- (D) as described in the Materials and
Methods. Results represent the mean65th and 95th percentile (*P=0.025, analyzed by Student’s t-test). No statistically significant differences were
found in IL-10, IL-6, and NO2
-/NO3
- levels.
doi:10.1371/journal.pone.0008406.g001
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patients, that early elevation in TNF-a following substantial injury
was associated with survival. These results further suggested that in
settings in which injury was below a certain threshold (i.e., in the
swine subjected to minor cannulation surgery only), only mild
inflammation was induced. To further test these hypotheses, we
sought to carry out additional studies in swine subjected to a larger
degree of T/HS.
Inflammation Following Hemorrhagic Shock Pigs
Combined with Anterolateral Thoracotomy (Group B)
A total of 11 (7 survivors and 4 non-survivors) swine were studied
in Group B (Fig. 5); as for Group A, the hemorrhage protocol is
depicted in Fig. 3A and the blood sampling protocol is depicted in
Fig. 3B. Shed blood volume in this group was 700648 ml in
survivors and 6626138 ml in non-survivors. The mean number of
bleeds in both survivors and non-survivors was 3, and the mean
percent of total volume of blood shed was between 20 and 22 in
both survivors and non-survivors. The time to resuscitation in
survivors was 12966 min, whereas in non-survivors it was
99619 min, with no statistically significant difference between
resuscitation time (P=0.093). The longest time point prior to
resuscitation found in common in both survivors and non-survivors
was 90 min. Utilizing the same method of analysis as in Group A,
90 min was therefore the longest time point utilized for all
subsequent analyses.
As for Group A, we first examined the levels of TNF-a, IL-10,
IL-6, and NO2
-/NO3
- at all time points in survivors vs. non-
survivors (Fig. 6). In survivors, the mean levels of cytokines pre-
resuscitation were as follows: TNF-a (210623 pg/ml; range:
60–449 pg/ml), IL-10 (0.260.1 pg/ml; range: 0–3.8 pg/ml), and
IL-6 (18694 pg/ml; range: 0–87 pg/ml). NO2
-/NO3
- levels were
119611 mM (range: 27–264 mM). In non-survivors, the mean
levels of cytokines were as follows: TNF-a (144620 pg/ml; range:
48–350 pg/ml), IL-10 (3.1563 pg/ml; range: 0–63 pg/ml), and
IL-6 (40612 pg/ml; range: 0–209 pg/ml). NO2
-/NO3
- levels
were 140637 mM (range: 28–477 mM). No statistically significant
differences in these analytes were found between survivors and
non-survivors, however. Interestingly, IL-10 levels in the non-
survivors in Group B were significantly lower than those of the
non-survivors in Group A. In contrast, Group B IL-6 levels were
significantly higher in non-survivors vs. IL-6 levels in Group A
non-survivors. Finally, the NO2
-/NO3
- levels of Group B survivors
were significantly higher than the NO2
-/NO3
- levels of Group A
survivors (all cross-group comparisons were performed using the
Kruskal-Wallis One Way Analysis of Variance on Ranks, with
significance determined at P,0.05).
We next examined the trends in cytokines within groups. In
survivors, the mean serum TNF-a at baseline was 9469 pg/ml.
Statistically significant elevations vs. baseline in TNF-a were
observed at 60 min (223652 pg/ml) and 90 min (239651 pg/ml)
post-hemorrhage (Fig. 7A). In contrast, and similarly to Group A,
the mean baseline TNF-a value in non-survivors was similar
to that of the survivors (88619 pg/ml), and no statistically
significant change occurred either following surgery or during
Figure 2. Plasma cytokine levels and Marshall organ damage scores in human trauma patients. Plasma samples from 23 patients (19
survivors and 4 non-survivors) taken within the first 6 h following trauma were assayed for TNF-a (A,B) and IL-6 (C,D) (as described in the Materials
and Methods) and correlated with Marshall organ damage scores. [(*P,0.05, analyzed by Spearman’s rank correlation coefficient (r)].
doi:10.1371/journal.pone.0008406.g002
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the hemorrhage period (Fig. 7B). We observed no statistically
significant change in IL-10 from baseline in either survivors
(Fig. 7C) or non-survivors (Fig. 7D) at any time point post-surgery.
IL-6 levels were statistically significantly different at 90 min vs.
preoperative baseline only in survivors (P=0.02; Fig. 7E). The
levels NO2
-/NO3
- (Figs. 7G-7H) were uniformly low in both
survivors and non-survivors at baseline, and did not change
significantly over the time course analyzed.
As in Group A, the control group (surgery only) for Group B
(Supplementary Materials, Fig. S2 and Table S2) exhibited similar pre-
operative baseline mean levels of all cytokines and NO2
-/NO3
-,
that remained low throughout the observation time period (5 h).
Figure 3. Hemorrhage and sampling protocols for swine T/HS experiments. (A) Hemorrhage protocol. After surgery, animals were stabilized
for 15 min. The animals were bled to a MAP of 30 mmHg. Resuscitation was initiated when decompensation occurred, defined by the in the variables
in the figure. (B) Blood sampling time points. Every 30 min, blood samples were derived for analysis of TNF-a, IL-10, IL-6, and NO2
-/NO3
-.
doi:10.1371/journal.pone.0008406.g003
Robust Inflammation in Trauma
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The levels of these inflammatory analytes were as follows: TNF-a
(mean levels pre-operative baseline 8265 pg/ml vs. 86610 pg/ml
at the end; Fig. S2A), IL-10 (below detection limit at baseline as
well as at the end; Fig. S2B), IL-6 (below detection limit at baseline
vs. 464 pg/ml at the end; Fig. S2C), and NO2
-/NO3
- (63621 mM
vs. 53621 mM at the end; Fig. S2D). Taken together, these results
supported the hypothesis that early inflammation was associated
with survival, and that sub-threshold, survivable injury did not
induce substantial inflammation.
Discussion
The biology of inflammatory cytokines and related products
such as NO is highly complex [8,9], and especially so in very acute
processes such as the response to T/HS [7,10,11]. This complexity
is not surprising. Inflammation may be considered as a
communication network that must integrate various stimuli and
orchestrate an appropriate set of responses to these stimuli, in a
manner that depends on the nature of the initiating stimulus and
host-related factors (i.e. gender, age, and genetics). The acute
inflammatory response is integrated with various physiological
systems, an interaction that in the setting of T/HS acts both as a
means of relaying information about the nature of the insult and as
an outcome (e.g. degree of decompensation). Due to this
complexity, extreme care must be taken when attempting to use
cytokines as diagnostic and prognostic markers of outcome
following T/HS [28], especially so if cytokines are to be future
therapeutic alternatives [29].
Our primary goal in the present study was to examine a central
question relating to the role of cytokines in post-T/HS
inflammation: is early, robust inflammation–whose hallmark is
the elevation of inflammatory cytokines such as TNF-a–associated
with benefit or detriment? More specifically, we sought to associate
the early inflammatory response of swine to T/HS with 1) the
need for resuscitation and 2) response to later resuscitation
(survival). In parallel, we sought to determine if the phenomena
observed in the setting of experimental T/HS also held true in
human T/HS.
Our studies suggest that a robust, early TNF-a response is
associated with survival in trauma victims, a finding supported by
data in large experimental animals subjected to T/HS. Indeed, the
trauma patient cohort examined, both survivors and non-
survivors, exhibited an inverse correlation between TNF-a
production and organ damage/dysfunction. Moreover, this
inverse correlation was observed even within the survivor sub-
group, suggesting that early TNF-a serve either to limit organ
damage or to induce reparative processes. While elevated plasma
levels of TNF-a have been found in both hemorrhagic shock
patients [30–32] and in experimental animal models [33–35], our
results suggest that this early, alarm-phase cytokine may need to be
recast as being beneficial when indicating a self-limiting form of
inflammation that signals for healing of injury.
Figure 4. Plasma cytokine and nitrite/nitrate levels in survivors vs. non-survivors in a porcine model of hemorrhagic shock. Plasma
samples from 12 pigs (9 survivors and 3 non-survivors) taken at different time points (see Figs. 3A and 5) were assayed for TNF-a (A), IL-10 (B), IL-6 (C)
and NO2
-/NO3
- (D) as described in the Materials and Methods. Results represent the mean65th and 95th percentile (*P,0.05 vs. non-survivors,
analyzed by Mann-Whitney Rank Sum Test).
doi:10.1371/journal.pone.0008406.g004
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Figure 5. Time course of plasma cytokine and nitrite/nitrate levels in a porcine model of hemorrhagic shock. Plasma samples from 12
pigs (9 survivors and 3 non-survivors) taken at different time points (see Fig. 3A) were assayed for TNF-a (A, B), IL-10 (C, D), IL-6 (E, F) and NO2
-/NO3
-
(G, H) as described in the Materials and Methods. Results represent the mean6SEM [*P,0.05 vs. baseline (BL), analyzed by One-Way ANOVA followed
by the Tukey post hoc test]. The TNF-a levels (0–75 min) in survivors (A) were also statistically different from the levels measured in non-survivors (B),
indicated by {. The IL-10 levels (at 0, 15 and 60 min) in non-survivors (D) were statistically different from the levels measured in survivors (C), indicated
by {. BL: baseline.
doi:10.1371/journal.pone.0008406.g005
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The concept that inflammation is beneficial post-trauma may,
at first glance, appear to contradict a large body of literature that
points to morbidity and mortality associated with elevated
inflammatory cytokines post-T/HS. However, attempts at mod-
ulating the canonical early pro-inflammatory cytokine TNF-a in
the setting of T/HS have had mixed results. Bemelmans et al.
found that administering anti-TNF-a antibodies to jaundiced mice
subjected to surgical trauma was not associated with improvement
in survival [36]. Similarly, mortality of wild-type mice subjected to
hemorrhagic shock was unaffected by pre-treatment with anti-
TNF-a antibodies [37]. In contrast, Zingarelli et al. found that ant-
TNF-a antibodies improved survival in an extremely severe
paradigm of hemorrhagic shock in rats (death by 30 minutes post-
hemorrhage) [38]. Various studies suggested improvements in
histological parameters following treatment with anti-TNF-a in
the settings of T/HS, but did not document effects on survival. For
example, Marzi et al. found that anti-TNF-a antibodies attenuated
leukocyte adhesion in the livers of rats subjected to HS [39], and
Abraham et al. found evidence of reduced lung inflammation [40].
Indeed, a closer look suggests that the primary elevated
inflammatory cytokine is IL-6, which we have suggested through
computational studies may be indicative of a positive feedback
loop of inflammationRtissue damage/dysfunctionRinflammation
[15] Interleukin-6 is arguably the best biomarker of outcome of
trauma patients with Systemic Inflammatory Response Syndrome,
sepsis, and Multiple Organ Failure [13,25]. Though we observed a
weak, positive correlation between circulating IL-6 and Marshall
Score, we did not observe any significantly elevated levels of
IL-6 in either human or porcine T/HS. Ayala et al. found that
IL-6 increased continuously post-hemorrhage and was already
increased after midline laparotomy and before initiation of
hemorrhage compared with non-manipulated animals, while
TNF-a was only detected once hemorrhage was initiated
[35,41]. These studies suggested that soft tissue trauma might be
a potent stimulus to the production of IL-6 [41]. Our experiments
comparing hemorrhaged animals to their surgery-only controls
support these studies, but suggest that there is a threshold for
overall injury that must be exceeded before TNF-a elevations are
observed in the circulation.
An evolving literature points to a central role for the release of
‘‘alarm/danger’’ signals (also known as ‘‘Damage-Associated
Molecular Pattern’’ molecules) which may damage tissues and
cause the dysfunction of organs, and re-induce the release of TNF-
a in a vicious cycle [42,43]. In the present study, we found a
positive association between IL-6 and organ dysfunction in trauma
patients, as well as elevated plasma IL-6 levels after 60 min of
hemorrhage in swine, consistent with this notion. The levels of IL-
6 have been repeatedly reported to be elevated in both animal and
clinical studies of T/HS [35,41,44–47]. We note that in our
relatively short-term animal study, there was no difference in IL-6
levels between survivors and non-survivors; additionally, the
relationship between early IL-6 levels and late complications after
Figure 6. Plasma cytokine and nitrite/nitrate levels in survivos vs. non-survivors in a swine model of anterolateral thoracotomy +
hemorrhagic shock. Plasma samples from 11 swine (7 survivors and 4 non-survivors) taken at different time points (see Figs. 3A and 7) were
assayed for TNF-a (A), IL-10 (B), IL-6 (C) and NO2
-/NO3
- (D) as described in the Materials and Methods. Results represent the mean65th and 95th
percentile.
doi:10.1371/journal.pone.0008406.g006
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trauma and hemorrhage was not studied. Our results therefore
suggest that, as in contrast to sepsis [48], early elevations of IL-6
may play a prominent role in the response to T/HS. Later
elevations in IL-6 are also associated with morbidity [49,50], and
thus persistent elevations in IL-6 may be indicative of self-
sustaining, tissue-damaging inflammation.
TH2 cytokines, central among them IL-10, are thought to
contribute to immunosuppression and the development of sepsis
Figure 7. Time course of plasma cytokine and nitrite/nitrate levels in a porcine model of hemorrhagic in combination with
anterolateral thoracotomy. Plasma samples from 11 swine (7 survivors and 4 non-survivors) taken at 0, 30, 60 and 90 min (see Fig. 3A) were
assayed for TNF-a (A, B), IL-10 (C, D), IL-6 (E, F) and NO2
-/NO3
- (G, H) as described in the Materials and Methods. Results represent the mean6SEM
[*P,0.05 vs. baseline (BL), analyzed by One-Way ANOVA followed by the Tukey post hoc test]. BL: baseline.
doi:10.1371/journal.pone.0008406.g007
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[7]. IL-10, which is characterized as an anti-inflammatory
cytokine [23,31,51,52] was assessed in T/HS patients [53] and
found to be a potent down-regulator of cell-mediated immune and
pro-inflammatory responses [54,55]. Experimental studies have
demonstrated that IL-10 inhibits the production of pro-inflamma-
tory cytokines, such as TNF-a and IL-6, by activated macrophages
[54–57]. Moreover, it has been demonstrated that IL-10 is an
immunosuppressant in animal models of T/HS [58]. We suggest
that at early time points following trauma, circulatory and the
neuro-endocrine derangements lead to the production of cate-
cholamines, which in turn induce this later production of IL-10
[29,33,59,60]. Overly elevated IL-10 could suppress TNF-a
produced by monocyte/macrophages in multiple tissues [56],
perhaps accounting for the cytokine phenotype we have observed
in non-survivor pigs. Investigators have suggested the possibility of
gene therapy with IL-10 for acute inflammatory syndromes such
as T/HS [61–64]; our studies suggest that caution should be
exercised when considering intervention using this cytokine.
Finally, since NO contributes to the host’s inflammatory defense
and can cause circulatory disorders, it may be an important
mediator in the setting of inflammation and organ failure, possibly
by altering outcome after T/HS [13]. Endothelial cells produce
NO from a largely constitutive isoform of NO synthase (NOS),
whose expression and activity is known to be reduced in
hemorrhagic shock [65–67]. Most cells also produce NO via an
inducible form of NOS (iNOS), the expression of which is induced
by cytokines [68] Elevated NO2
-/NO3
- levels in trauma patients
have been previously reported both immediately after trauma [69]
and at later time points [70]. This elevated NO production
reflected severity of injury during the first two hours after the
traumatic insult, suggesting that increased NO production might
play a role in the very early post-injury period [71]. Other studies
have focused on NO as a possible mediator of decompensation,
with increases in iNOS activity being reported in several organs
after prolonged hemorrhagic shock [72].
In the present study, we observed significant differences
between survivors and non-survivors only in Group A swine only
when the NO2
-/NO3
- data were taken as a whole for each
outcome group, but not in trauma patients and not as a function of
time in injured swine. These results suggest that iNOS is probably
not involved in the phenomena studied herein, though they may
suggest that eNOS activity is altered in some settings (consistent
with prior findings [65–67]). The lack of a role for iNOS in swine
may reflect the early time points studied. Alternatively, the activity
of eNOS might be affected differentially in T/HS survivors vs.
non-survivors, but the relative insensitivity of NO2
-/NO3
- as a
measurement outcome may necessitate alternative methods (e.g.
directly measuring NO by a NO-sensitive electrode or other
means [73]) to address this point.
A general limitation of our study centers on the fact that the
overall number of subjects and inflammatory analytes studied was
relatively low in both humans and swine. With regard to patient
number, we believe that our data (17% mortality rate) are
representative of the type of outcomes seen in patients presenting
with blunt trauma (e.g. the stud of Sperry et al. [49], in which only
5% mortality is reported in trauma patients). Given this limitation,
we augmented our study by assaying inflammatory analytes in
serial samples from trauma patients. We also carried out a
clinically realistic animal model of trauma/hemorrhage, in which
defined alarms triggered resuscitation and led to a low mortality
that is concordant with that seen in trauma patients. We believe
that our results are valid because even when examining all samples
from all patients (both survivors and non-survivors) we found a
negative correlation between early circulating TNF-a levels and
organ damage, suggesting that an early pro-inflammatory response
is associated with a positive outcome. In the same cohort,
circulating IL-6 correlated positively with organ damage, as would
be expected from a large number of studies that have examined
circulating IL-6 in trauma patients (thereby helping validate, at
least in part, the cohort of patients studied herein). The choice of
cytokines utilized in the analysis described in the present
manuscript was based on a defined number of cytokines that
have been well-vetted with regard to their role in trauma/
hemorrhage (as described above) and that could be measured in
both humans and swine. We hope that as the number of available
pig-specific cytokine assay kits increases, we will be able to expand
the present study to a broader panel of inflammatory mediators.
Another caveat that needs to be considered with regard to our
studies in swine concerns the experimental protocol used. Our
model of severe hemorrhagic shock allows for a wide range of
hemodynamic fluctuations in the course of the experiment and
reflects the animals’ compensatory responses. Not surprisingly, this
experimental paradigm was associated with significant inter-
animal variability in both time course and outcome. Furthermore,
analysis was carried out up only to the pre-resuscitation time point
due to the fact that resuscitation has been shown to influence the
inflammatory response to trauma and hemorrhage [74]. Ideally,
swine should be subjected to a combination of soft tissue injury
and bone fracture, in combination with mild to moderate
hemorrhagic shock, in order to simulate the types of blunt injury
seen in trauma patients. However, due to limitations placed on us
by animal use regulations, we cannot easily carry out such studies,
and moreover could not carry out such studies and then recover
the animals and follow them for 1–2 days. Nonetheless, we suggest
that the characteristics of our experimental preparation render it
particularly suitable for the practical assessment of dynamic
response characteristics, and especially since one of our central
goals was to compare the responses of large experimental animals
with those of human trauma victims.
Alternative hypotheses may be raised with regard to our
findings. Higher circulating levels of TNF, IL-6, IL-10, and NO2
-/
NO3
- are found in septic patients [70,75–77]. In one study, higher
levels of plasma cytokines were reported in non-survivors of sepsis,
and in this study fluid resuscitation was associated with lower
mean cytokine levels [77]. Rivers et al. have hypothesized that
better perfused organs suffer less damage/dysfunction, and thus
are less inflamed [78]. Thus, it may be argued that trauma results
in such profound hypoperfusion that cytokines are not flushed out
of damaged organs, contrary to sepsis, where many organs remain
perfused. This alternative hypothesis could be tested (at least in
experimental animals) by quantifying tissue levels of cytokines.
Another limitation of our comparative study in humans and
swine involves a somewhat different sampling methodology in
these two species; clearly, we were able to sample blood in
experimental animals more frequently than in trauma patients.
Despite the fact the time points in both settings fell within a 6-h
range, it may be argued that we are observing different kinetics of
cytokine production and therefore different phenomena.
In conclusion, our studies suggest that the role of TNF-a in
T/HS may need to be re-evaluated in light of our findings. On a
broader level, there may be a need to distinguish between early
and late inflammation induced by injury. Our studies suggest that
early, adequately robust production of TNF-a following injury is a
hallmark of a proper response, while unchanging, low-levels of this
cytokine may reflect pathology. This situation may be analogous to
that observed when studying physiologically variable responses
such as heart rate [79–81]. Though further study is warranted, our
findings raise the possibility of re-interpreting the role of TNF-a
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post-T/HS, and suggest that caution should exercised when
thinking of TNF-a antagonism in this setting.
Supporting Information
Table S1 Circulating cytokine levels in swine subjected to
experimental T/HS. See Materials and Methods for details.
HS=Hemorrhagic Shock, HS + T=Hemorrhagic Shock +
Thoracotomy, n= number of animals/condition.
Found at: doi:10.1371/journal.pone.0008406.s001 (0.07 MB
DOC)
Table S2 Circulating cytokine levels in swine subjected to experi-
mental Surgery and Surgery with Thoracotomy. See Materials and
Methods for details. n = number of animals/condition.
Found at: doi:10.1371/journal.pone.0008406.s002 (0.08 MB
DOC)
Figure S1 Plasma cytokine and nitrite/nitrate levels in pigs
subjected to surgical cannulation only. Plasma samples from 3
swine (all survivors) taken at different time points (see Fig. 2B) were
assayed for TNF-a (A), IL-10 (B), IL-6 (C) and NO2
-/NO3
- (D) as
described in the Materials and Methods. Results represent the
mean6SEM (*P,0.05 vs. baseline, analyzed by One-Way
ANOVA followed by the Tukey post hoc test).
Found at: doi:10.1371/journal.pone.0008406.s003 (0.19 MB TIF)
Figure S2 Plasma cytokine and nitrite/nitrate levels in pigs
subjected to surgical cannulation in combination with anterolat-
eral thoracotomy only. Plasma samples from 4 swine (all survivors)
taken at different time points (see Fig. 2B) were assayed for TNF-a
(A), IL-10 (B), IL-6 (C) and NO2
-/NO3
- (D) as described in the
Materials and Methods. Results represent the mean6SEM (*P,0.05
vs. baseline, analyzed by One-Way ANOVA followed by the
Tukey post hoc test).
Found at: doi:10.1371/journal.pone.0008406.s004 (0.19 MB TIF)
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